Bureaucrats, beagles and backlash: What can we learn about a regulated “legal high” market 3 months into New Zealand’s novel approach?

Ross Bell, Executive Director of the New Zealand Drug Foundation, will provide an update about New Zealand’s world-first attempt to regulate New Psychoactive Substances. Ross will highlight some of the devils that have been found in the details of implementing a new regulatory regime, including public backlash during the transition phase, delays in promulgating regulations and the matter of determining risk using animal testing.